Bioavailability of valsartan oral dosage forms-Reference-Cited by-同舟云学术

Bioavailability of valsartan oral dosage forms

Published:2013-10-10 Issue:2 Volume:3 Page:132-138
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:

Author:

Sunkara Gangadhar¹,Bende Girish²,Mendonza Anisha E.³,Solar-Yohay Susan⁴,Biswal Shibadas²,Neelakantham Srikanth⁵,Wagner Robert⁴,Flarakos Jimmy¹,Zhang Yiming⁴,Jarugula Venkateswar¹

Affiliation:

1. Novartis Institutes for Biomedical Research; East Hanover NJ USA

2. Novartis Institutes for Biomedical Research; Hyderabad India

3. Novartis Institutes for Biomedical Research; Cambridge MA USA

4. Novartis Pharmaceuticals Corporation; East Hanover NJ USA

5. Novartis Healthcare Pvt. Ltd.; Hyderabad India

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpdd.56/fullpdf

Reference24 articles.

1. Hypertension in children and adolescents;Luma;Am Fam Physician.,2006

2. Hypertension in children;Sinaiko;N Engl J Med.,1996

3. Overweight, ethnicity, and the prevalence of hypertension in school-aged children;Sorof;Pediatrics.,2004

4. Evaluation and management of hypertension in children and adolescents (part one): diagnosis;Cromwell;J Pediatr Health Care.,2005

5. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents;National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents;Pediatrics.,2004

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetic implementation for CYP2C19 and pharmacokinetics of voriconazole in children with malignancy or inborn errors of immunity;Journal of Infection and Chemotherapy;2024-06

2. Differences in in vivo absorption of flavone glycosides, flavone aglycones and terpene lactones under different dosage forms and physiological conditions;Journal of Ethnopharmacology;2023-04

3. Quality by design approach for development and validation of a RP-HPLC method for simultaneous estimation of xipamide and valsartan in human plasma;BMC Chemistry;2022-09-20

4. The Bioequivalence Between Valsartan Oral Solution and Suspension Formulations Developed for Pediatric Use;Clinical Pharmacology in Drug Development;2022-01-20

5. Integrated Analytical Quality by Design (AQbD) Approach for the Development and Validation of Bioanalytical Liquid Chromatography Method for Estimation of Valsartan;Journal of Chromatographic Science;2020-07-13